DK0785792T3 - Præparat til behandling af ovariale af østrogen afhængige sygdomme - Google Patents

Præparat til behandling af ovariale af østrogen afhængige sygdomme

Info

Publication number
DK0785792T3
DK0785792T3 DK95910179T DK95910179T DK0785792T3 DK 0785792 T3 DK0785792 T3 DK 0785792T3 DK 95910179 T DK95910179 T DK 95910179T DK 95910179 T DK95910179 T DK 95910179T DK 0785792 T3 DK0785792 T3 DK 0785792T3
Authority
DK
Denmark
Prior art keywords
preparation
treatment
dependent diseases
estrogen dependent
ovarian estrogen
Prior art date
Application number
DK95910179T
Other languages
Danish (da)
English (en)
Inventor
Gary D Hodgen
Robert F Williams
Daniel Grow
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Application granted granted Critical
Publication of DK0785792T3 publication Critical patent/DK0785792T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK95910179T 1994-02-04 1995-02-02 Præparat til behandling af ovariale af østrogen afhængige sygdomme DK0785792T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/191,631 US5681817A (en) 1994-02-04 1994-02-04 Treatment of ovarian estrogen dependent conditions
PCT/US1995/001479 WO1995020972A1 (en) 1994-02-04 1995-02-02 Treatment of ovarian estrogen dependent conditions

Publications (1)

Publication Number Publication Date
DK0785792T3 true DK0785792T3 (da) 1999-10-18

Family

ID=22706258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95910179T DK0785792T3 (da) 1994-02-04 1995-02-02 Præparat til behandling af ovariale af østrogen afhængige sygdomme

Country Status (29)

Country Link
US (1) US5681817A (lv)
EP (1) EP0785792B1 (lv)
JP (1) JP3130048B2 (lv)
KR (1) KR970700507A (lv)
CN (1) CN1144486A (lv)
AP (1) AP724A (lv)
AT (1) ATE179610T1 (lv)
AU (1) AU689229B2 (lv)
BG (1) BG62238B1 (lv)
BR (1) BR9506606A (lv)
CA (1) CA2182183C (lv)
CZ (1) CZ291709B6 (lv)
DE (1) DE69509544T2 (lv)
DK (1) DK0785792T3 (lv)
ES (1) ES2132645T3 (lv)
FI (1) FI963036A0 (lv)
GR (1) GR3030164T3 (lv)
HU (1) HUT74622A (lv)
LT (1) LT4182B (lv)
LV (1) LV11782B (lv)
MD (1) MD1432C2 (lv)
NZ (1) NZ281441A (lv)
OA (1) OA10777A (lv)
PL (1) PL178273B1 (lv)
RO (1) RO117420B1 (lv)
RU (1) RU2110274C1 (lv)
SK (1) SK96296A3 (lv)
TJ (1) TJ242B (lv)
WO (1) WO1995020972A1 (lv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1137722C (zh) * 1994-07-22 2004-02-11 汉普顿路医学院 为长期治疗方案确立基础(tonic)卵巢雌激素分泌
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
EP1029868A4 (en) 1997-10-17 2003-10-22 Mochida Pharm Co Ltd AGENT AGAINST HYSTEROMYOMAS CONTAINS DIENOGEST AS AN ACTIVE SUBSTANCE
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
PT1229906E (pt) * 1999-08-31 2008-01-18 Bayer Schering Pharma Ag Mesoprogestinas para o tratamento e prevenção de distúrbios ginecológicos hormonodependentes benignos
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
AU2001295359A1 (en) * 2000-10-30 2002-05-15 University Of Zurich GnRH analogues for treatment of urinary incontinence
US7029657B2 (en) * 2002-08-02 2006-04-18 Balance Pharmaceuticals, Inc. Nasal spray steroid formulation and method
US6958142B2 (en) * 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
US6960337B2 (en) * 2002-08-02 2005-11-01 Balance Pharmaceuticals, Inc. Methods and compositions for treating benign gynecological disorders
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
EP2316441A1 (en) * 2005-02-17 2011-05-04 Hadasit Medical Research Services And Development Bisphosphonates for treating endometriosis
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US20060251581A1 (en) * 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
SI3263112T1 (sl) * 2006-10-24 2020-10-30 Allergan Pharmaceuticals International Limited Sestavki in metode za zaviranje endometrijskih proliferacij
TWI455716B (zh) * 2006-10-24 2014-10-11 Repros Therapeutics Inc 選擇性黃體激素受體調節劑用於製造治療雌激素依賴性病症之藥物的用途
WO2008144143A1 (en) * 2007-05-14 2008-11-27 Drugtech Corporation Endometriosis treatment
EP2197415B1 (en) * 2007-09-20 2014-03-05 Lapidot Medical Import And Marketing Ltd Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone
RU2359684C1 (ru) * 2008-01-23 2009-06-27 Закрытое акционерное общество "СКАЙ ЛТД" Способ лечения эндометриоза
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
KR101585221B1 (ko) 2014-02-27 2016-01-13 권희완 지압대 겸용 지압 베개
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3347126A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
ATE86484T1 (de) 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
DE3744054A1 (de) 1987-12-21 1989-06-29 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
DE3921059A1 (de) 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
JP3112172B2 (ja) 1990-03-16 2000-11-27 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ ベノートスハップ 多嚢胞卵巣疾病の治療
US6827050B2 (en) 2001-12-21 2004-12-07 Caterpillar Inc Fluid control valve actuating system
US7283632B2 (en) 2003-09-09 2007-10-16 The Boeing Company Unauthorized access embedded software protection system

Also Published As

Publication number Publication date
JP3130048B2 (ja) 2001-01-31
RO117420B1 (ro) 2002-03-29
HUT74622A (en) 1997-01-28
GR3030164T3 (en) 1999-08-31
CA2182183C (en) 2003-09-16
PL315792A1 (en) 1996-12-09
CN1144486A (zh) 1997-03-05
HU9601969D0 (en) 1996-09-30
CZ291709B6 (cs) 2003-05-14
EP0785792A4 (lv) 1997-07-30
JPH09508418A (ja) 1997-08-26
BG62238B1 (bg) 1999-06-30
RU2110274C1 (ru) 1998-05-10
AP9600840A0 (en) 1996-07-31
BG100766A (en) 1997-06-30
DE69509544D1 (de) 1999-06-10
FI963036A (fi) 1996-08-01
FI963036A0 (fi) 1996-08-01
AU1838695A (en) 1995-08-21
NZ281441A (en) 1999-09-29
MD1432C2 (ro) 2000-09-30
CA2182183A1 (en) 1995-08-10
AU689229B2 (en) 1998-03-26
ES2132645T3 (es) 1999-08-16
LT4182B (en) 1997-06-25
SK96296A3 (en) 1997-07-09
CZ210396A3 (en) 1997-05-14
DE69509544T2 (de) 1999-09-02
PL178273B1 (pl) 2000-03-31
US5681817A (en) 1997-10-28
MD1432B2 (en) 2000-03-31
KR970700507A (ko) 1997-02-12
EP0785792A1 (en) 1997-07-30
BR9506606A (pt) 1997-09-09
OA10777A (en) 2002-12-23
WO1995020972A1 (en) 1995-08-10
ATE179610T1 (de) 1999-05-15
EP0785792B1 (en) 1999-05-06
LT96133A (en) 1997-01-27
TJ242B (en) 1999-11-24
LV11782A (lv) 1997-06-20
AP724A (en) 1999-01-18
LV11782B (en) 1997-12-20

Similar Documents

Publication Publication Date Title
DK0785792T3 (da) Præparat til behandling af ovariale af østrogen afhængige sygdomme
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK1032566T5 (da) Fremgangsmåde til fremstilling af citalopram
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK0812357T3 (da) Fremgangsmåde til fremstilling af heteromultimere polypeptider
DK0820276T3 (da) Fremgangsmåde til fremstilling af respirerbare partikler
DK0773940T3 (da) Fremgangsmåde til syntese af substituerede sulfoxider
DK0807086T3 (da) Fremgangsmåde til fremstilling af hydrotalciter
DK0747116T3 (da) Fremgangsmåde til fremstilling af mikrokapselsammensætninger
DK0775100T3 (da) Fremgangsmåde til fremstilling af trifluorethylen
DK0670835T3 (da) Fremgangsmåde til fremstilling af benzopyranforbindelser
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0756597T3 (da) Fremgangsmåde til fremstilling af puriner
DK0839138T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK0873326T3 (da) Fremgangsmåde til fremstilling af 2-chlorthiazolforbindelser
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0946531T3 (da) Fremgangsmåde til fremstilling af thiazol-derivater
DK0923599T3 (da) Fremgangsmåde til fremstilling af 17-estere af 9alfa, 21-dihalogenpregnan-11beta, 17alfa-diol-20-oner
DK0880498T3 (da) Fremgangsmåde til fremstilling af diketonforbindelser
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK0846691T3 (da) Fremgangsmåde til fremstilling af 3-(1-hydroxyphenyl-1-alkoximinomethyl)dioxaziner
DK0648738T3 (da) Fremgangsmåde til fremstilling af acetoacetarylamider
DK0721929T3 (da) Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner